J. Colin R. Hunter


Home
13 Spring Head Court, Apt. E
Cockeysville, Hunt Valley
Hunt Valley
MD 21030-4113

410-628-7290

Work
Virology Laboratories, MSTF Room 500-F
University of Maryland at Baltimore
10 S. Pine Street
MD 21201

410-706-3895


Email
chunter@umabnet.ab.umd.edu (preferred)
chunter@fconvx.ncifcrf.gov


OBJECTIVE

A career in the biomedical/biocomputing industry utilizing and expanding upon my extensive training in molecular biology as well as my computing skills.

UNIVERSITY DEGREES

Ph.D. University of Maryland at Baltimore 1995
M.Sc. University of St. Andrews, U.K. 1986
B.Sc. (Hons.) University of Aberdeen, U.K. 1985


BIO-SKILLS
COMPUTER SKILLS

Professional Organizations

Chesapeake Society of Electron Microscopists (1993 - present)



References

Dr. L. Aurelian,
Virology Laboratories, MSTF Room 500-F
University of Maryland at Baltimore
10 South Pine Street,
Baltimore, MD 21201
Tel: 410-706-3895


Dr. R. Feldman
BRB Room 13-03
University of Maryland at Baltimore
655 West Baltimore Street
Baltimore, MD 21201
Tel: 410-706-4198


Dr. C. Smith
Virology Laboratories, MSTF Room 500-F
University of Maryland at Baltimore
10 South Pine Street
Baltimore, MD 21201
Tel: 410-706-3895





Publications

Wachsman, M., Aurelian, L., Hunter, J.C.R., Perkus, M.E. and Paoletti, E. (1988) Expression of herpes simplex virus glycoprotein D on antigen presenting cells infected with vaccinia recombinants and protective immunity. Bioscience Reports, 8: 32-334.

Hunter, J.C.R. and Lewis, G.K. (1990) Underestimation of the responder phenotype by conventional T cell proliferative assays. Clinical Biotechnology, 2: 4-46

Kulka, M. Smith, C.C. Levis, J. Fishelevich, R. Hunter J.C.R., Cushman, C.D. (1994) Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1. Antimicrobial Agents and Chemotherapy. 38: 675-80

Smith, C.C., Luo, J.H., Hunter, J.C.R., Ordonez, J.V. and Aurelian, L. (1994) The transmembrane domain of the large subunit of HSV-2 ribonucleotide Reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation. Virology, 200: 598-612.

Hunter, J.C.R., Smith, C.C., Bose, D., Kulka, M., Broderick, R. and Aurelian, L. (1995) Intracellular internalization and signaling pathways triggered by the large subunit of HSV-2 ribonucleotide reductase (ICP10). Virology, 210: 345-360

Hunter, J.C.R., Smith, C.C. and Aurelian, L. (1995) The HSV-2 LA-1 oncoprotein is a member of a novel family of serine/threonine receptor kinases. International Journal of Oncology, 7: 515-522